-13.75 (-2.37%)
-10.45 (-1.81%) 5.04 pm | 30 May 2012 | Source: CNBC-TV18
Uday Baldota, VP- investor relations, Sun Pharma tells CNBC-TV18 that apart from the drug Taro’s stellar contribution, other business segments also ...
11.17 am | 30 May 2012 | Source: Moneycontrol.com
Drug maker Sun Pharma posted a spectacular 85% jump in March quarter net profit at Rs 820 crore, driven by strong sales of its Israeli unit Taro. ...
11.00 am | 30 May 2012 | Source: Moneycontrol.com
Sun Pharmaceutical expects 18-20% sales growth in the current fiscal year that started in April, Managing Director Dilip Shanghvi said in an earnings ...
5.41 pm | 29 May 2012 | Source: Moneycontrol.com
Sun Pharmaceutical Industries has announced its fourth quarter results. The company's Q4 consolidated net profit was up85% at Rs 820 crore versus Rs ...
9.17 am | 25 May 2012 | Source: Moneycontrol.com
Taro, a subsidiary of Sun Pharma, showed good growth in January-March quarter of 2012 on year-on-year basis, but there was dip in margins sequentially...